Earnings calendar/RARE
Ultragenyx Pharmaceutical Inc. (RARE)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-0.65
Street estimate
Revenue target
$183.7M
Street estimate
Trailing EPS (avg 4Q)
$-1.46
Beat rate last 4: 25%
Latest EPS YoY
+23.1%
vs 2025-08-05
Latest revenue YoY
+28.5%
How results look so far
Trailing revenue (avg 4Q)
$179.2M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 4, 2026
EPS beat
EPS actual / est
$-0.90 / $-1.22
+26.2%
Revenue actual / est
$214.0M / $183.1M
+16.9%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-0.65 | Pending | — | $183.7M | Pending | — |
| 8/4/2026 | $-1.22 | $-0.90 | +26.2% | $183.1M | $214.0M | +16.9% |
| 5/5/2026 | $-1.49 | $-1.84 | -23.7% | $158.2M | $136.0M | -14.0% |
| 2/12/2026 | $-1.20 | $-1.29 | -7.5% | $198.6M | $207.0M | +4.2% |
| 11/4/2025 | $-1.23 | $-1.81 | -47.2% | $199.8M | $159.9M | -19.9% |
| 8/5/2025 | $-1.27 | $-1.17 | +7.9% | $165.9M | $166.5M | +0.3% |
| 5/6/2025 | $-1.54 | $-1.57 | -1.9% | $162.4M | $139.3M | -14.2% |
| 2/13/2025 | $-1.32 | $-1.39 | -5.3% | $158.7M | $164.9M | +3.9% |
| 11/5/2024 | $-1.45 | $-1.40 | +3.4% | $146.5M | $139.5M | -4.8% |
| 8/1/2024 | $-1.64 | $-1.52 | +7.3% | $123.2M | $147.0M | +19.4% |
| 5/2/2024 | $-1.72 | $-2.03 | -18.0% | $116.0M | $108.8M | -6.2% |
| 2/15/2024 | $-1.65 | $-1.52 | +7.9% | $119.4M | $127.4M | +6.7% |
| 11/2/2023 | $-2.08 | $-2.23 | -7.2% | $110.0M | $98.1M | -10.9% |
| 8/3/2023 | $-2.11 | $-2.25 | -6.6% | $104.8M | $108.3M | +3.3% |
| 5/4/2023 | $-1.97 | $-2.33 | -18.3% | $104.7M | $100.5M | -4.0% |
| 2/16/2023 | $-2.03 | $-2.16 | -6.4% | $105.1M | $103.3M | -1.7% |
| 11/2/2022 | $-2.29 | $-2.43 | -6.1% | $96.5M | $90.7M | -6.0% |
| 7/28/2022 | $-1.72 | $-2.26 | -31.4% | $87.8M | $89.3M | +1.8% |
| 5/5/2022 | $-1.76 | $-2.19 | -24.4% | $83.7M | $79.9M | -4.4% |
| 2/10/2022 | $-1.32 | $-1.79 | -35.6% | $83.8M | $83.4M | -0.5% |
| 11/2/2021 | $-1.43 | $-1.08 | +24.5% | $82.4M | $81.6M | -0.9% |
| 8/2/2021 | $-1.28 | $-1.45 | -13.3% | $87.0M | $87.0M | 0.0% |
| 5/4/2021 | $-1.25 | $-2.03 | -62.4% | $89.3M | $99.4M | +11.3% |
| 2/11/2021 | $-1.06 | $-1.34 | -26.4% | $225.7M | $91.5M | -59.4% |
| 10/27/2020 | $-1.24 | $-1.13 | +8.9% | $90.8M | $81.5M | -10.3% |
| 7/30/2020 | $-1.56 | $-0.82 | +47.4% | $231.8M | $61.7M | -73.4% |
| 5/6/2020 | $-1.60 | $-2.04 | -27.5% | $29.8M | $36.3M | +22.0% |
| 2/13/2020 | $-1.61 | $-1.64 | -1.9% | $36.3M | $35.6M | -1.8% |
| 11/5/2019 | $-1.71 | $-1.96 | -14.6% | $22.1M | $25.8M | +16.7% |
| 8/1/2019 | $-1.73 | $-1.72 | +0.6% | $23.9M | $24.1M | +1.2% |
| 5/6/2019 | $-1.73 | $-1.82 | -5.2% | $17.4M | $18.2M | +4.6% |
| 2/19/2019 | $-1.74 | $-1.73 | +0.6% | $16.8M | $16.3M | -3.4% |
| 11/5/2018 | $-1.94 | $-1.74 | +10.3% | $13.3M | $11.8M | -11.2% |
| 8/2/2018 | $-2.10 | $-1.87 | +11.0% | $25.1M | $12.8M | -49.0% |
| 5/7/2018 | $-0.60 | $0.62 | +203.3% | $3.3M | $10.7M | +226.3% |
| 2/20/2018 | $-2.00 | $-2.27 | -13.5% | $2.5M | $2.4M | -5.0% |
| 11/2/2017 | $-1.87 | $-1.87 | 0.0% | $97,475.94 | $198,000 | +103.1% |
| 7/27/2017 | $-1.73 | $-1.72 | +0.6% | — | Pending | — |
| 5/4/2017 | $-1.70 | $-1.63 | +4.1% | $104,907.98 | Pending | — |
| 2/16/2017 | $-1.74 | $-1.75 | -0.6% | $4,914.29 | $5,000 | +1.7% |
| 11/7/2016 | $-1.53 | $-1.64 | -7.2% | $103,554.88 | $111,000 | +7.2% |
| 8/8/2016 | $-1.47 | $-1.46 | +0.7% | $16,767.12 | $17,000 | +1.4% |
| 5/9/2016 | $-1.29 | $-1.35 | -4.7% | — | Pending | — |
| 2/25/2016 | $-1.11 | $-1.42 | -27.9% | — | Pending | — |
| 11/9/2015 | $-0.85 | $-1.03 | -21.2% | — | Pending | — |
| 8/13/2015 | $-0.62 | $-0.83 | -33.9% | — | Pending | — |
| 5/11/2015 | $-0.54 | $-0.63 | -16.7% | — | Pending | — |
| 3/25/2015 | $-0.53 | $-0.52 | +1.9% | — | Pending | — |
| 11/10/2014 | $-0.45 | $-0.50 | -11.1% | — | Pending | — |
| 8/11/2014 | $-0.41 | $-0.45 | -9.8% | — | Pending | — |
| 5/12/2014 | $-0.38 | $-0.85 | -123.7% | — | Pending | — |
| 3/24/2014 | $-0.38 | $-4.98 | -1210.5% | — | Pending | — |
| 6/30/2013 | — | $-0.37 | — | — | Pending | — |
| 3/31/2013 | — | $-0.29 | — | — | Pending | — |
| 12/31/2012 | — | $-1.46 | — | — | Pending | — |
Need RARE data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.